AAP Committee on Infectious Disease Update

Discussion in 'MedImmune' started by Anonymous, May 21, 2014 at 8:35 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What does this ultimately mean?

    The AAP COID recently changed their guidelines for Synagis (Palivizumab) administration to premature infants. These recommendations will result in fewer doses of antibody, especially for infants born at 32 weeks, 0 days to 34 weeks, 6 days of gestation. These infants will receive from 0 to a maximum of 3 doses of synagis, depending on other risk factors and when they are born. It also means a child born at 32 weeks, 0 days gestation born in July or a 29 week gestation infant born in May will not be eligible for synagis according to the COID recommendation. A 32 week gestation infant born in August will only receive a single dose of Synagis in November, well before the peak of RSV season. Studies showing protection from severe disease from RSV infection were based on a 5 dose schedule and were approved by the FDA based on that schedule. The COID used no studies to change their recommendation, and, in fact made recommendations that are not the same as the FDA package insert. If you think the COID synagis recommendation changes will adversely impact the health care of your premature infants, please e-mail the dhs consultants listed below with your opinion. Apparently several states have already stated that they will not be following the COID recommendations because of input from practicing physicians in those states.
     

  2. Anonymous

    Anonymous Guest


    Means we are all severely screwed
     
  3. Anonymous

    Anonymous Guest

    It's interesting that this info was open to the public on the AAP website, but now appears to be locked.
     
  4. Anonymous

    Anonymous Guest

    Nice try, these are the 2009 changes.
     
  5. Anonymous

    Anonymous Guest

    Well what's the latest ?
     
  6. Anonymous

    Anonymous Guest

    "a 29 week gestation infant born in May will not be eligible for synagis according to the COID recommendation".

    what?
     
  7. Anonymous

    Anonymous Guest

    That's what happens when you decimate the hospital reps that had local relationships with Ped ID's. You cut all the reps, and it cost you the key relationships that could've helped prevent the impending mess. Maybe Medi should push back by just not making the drug next year.
     
  8. Anonymous

    Anonymous Guest

    I agree with above post- sales continued to tumble once Medi got rid of the hospital folks. Those folks had all the heart in the world- worked their asses off and had stellar relationships- shame on those higher-ups - no longer at Medi - by the way - who listened to the whining BSS's who have not been able to maintain shit!
     
  9. Anonymous

    Anonymous Guest

    I totally agree it was a mistake to get rid of the CMM's. Everybody knows that was SC's call and he's gone. However, you're statements about BSS's are really rude. What do you expect when the price of Synagis continues to rise, the number of babies getting approved continues to decline, and you literally have one person doing the work of two jobs?
     
  10. Anonymous

    Anonymous Guest

    The continued stupidity and arrogance of those like you, former CMMs, is stunning. The CMMs were a mistake from the beginning. They were overpaid and lazy and did nothing but cause friction and strife. Hmmmm, some continue to do so as FRMs - another WORTHLESS and OVERPAID position.

    MedImmune has overpriced Synagis. It's been a not-so-closely-guarded secret about darts thrown on prices and it was priced where the dart landed. A small group of people have made billions on Synagis. This ride has gone on long enough and corporate greed has killed this product, not the decision to get rid of a bunch of do-nothing hospital reps.
     
  11. Anonymous

    Anonymous Guest

    You probably haven't been at Medi long enough to understand the origins of the CMM role.
     
  12. Anonymous

    Anonymous Guest

    Up yours a-hole. Bss's were busy enough without having the Nicu part of hospital rep job jammed down their throats. Sounds like you're a bit upset, poor baby.
     
  13. Anonymous

    Anonymous Guest

    First of all, quit saying "folks". Secondly, BSSs have demonstrated how easily the TOC form could be implemented in hospitals when all the CMMs did was say "it can't be done."
     
  14. Anonymous

    Anonymous Guest

    I agree with you
     
  15. Anonymous

    Anonymous Guest

    bla bla bla whine whine whine- you have 2 products to sell in the SAME MARKET- Its not hard!
     
  16. Anonymous

    Anonymous Guest

    All of you still there milking the Synagis cow, good luck on the job searches.
     
  17. Anonymous

    Anonymous Guest

    It's all over now.
    Ax drops tomorrow
     
  18. Anonymous

    Anonymous Guest

    thanks for the drive by. Kind of useless though if you have no insight to share.
     
  19. Anonymous

    Anonymous Guest

    A dose at discharge but only less than 29 wks if being dc'd during season.
    No others except if O2 depend and only 1 season.
    CHD only less than 29 and daily O2.

    But maybe I don't have any insight,
     
  20. Anonymous

    Anonymous Guest

    Yes, it will be much worse than anticipated if they tinkered with heart and lung patients also. Wonder if they altered age limit.